Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Parallax Health Sciences, Inc. (EDVP) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Parallax Health Sciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1388410.
Total stock buying since 2018: $586,500.
Total stock sales since 2018: $0.
Total stock option exercises since 2018: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 10,000,000 | $578,000 | 0 | $0 | 0 | $0 |
| 2018 | 8,500,000 | $8,500 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-12 | 4,000,000 | $200,000 | 0 | $0 | 0 | $0 |
| 2019-09 | 6,000,000 | $378,000 | 0 | $0 | 0 | $0 |
| 2018-04 | 8,500,000 | $8,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-12-31 | Bucci Calli (CFO, Secretary) | Buy | 2,000,000 | .05 | 100,000 |
| 2019-12-31 | Arena Paul R (CEO, President) | Buy | 2,000,000 | .05 | 100,000 |
| 2019-09-30 | Bradley Nathaniel T (Chief Technology Officer) | Buy | 1,600,000 | .06 | 100,800 |
| 2019-09-30 | Bucci Calli (CFO, Secretary) | Buy | 1,600,000 | .06 | 100,800 |
| 2019-09-30 | Ogden John L (Director) | Buy | 1,200,000 | .06 | 75,600 |
| 2019-09-30 | Arena Paul R (CEO, President) | Buy | 1,600,000 | .06 | 100,800 |
| 2018-04-06 | Arena Paul R (PRESIDENT) | Buy | 2,500,000 | .00 | 2,500 |
| 2018-04-05 | Bucci Calli (CFO) | Buy | 5,000,000 | .00 | 5,000 |
| 2018-04-05 | Withrow Edward W. Jr (Director) | Buy | 500,000 | .00 | 500 |
| 2018-04-05 | Ogden John L (Director) | Buy | 500,000 | .00 | 500 |
Insider trading activities including stock purchases, stock sales, and option exercises of EDVP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Parallax Health Sciences, Inc. (symbol EDVP, CIK number 1388410) see the Securities and Exchange Commission (SEC) website.